Skip to main content
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. — Investor Relations & Filings

Ticker · RKDA ISIN · US0390142042 LEI · 54930027ZPNA80B8O763 US Agriculture, forestry and fishing
Open in API
Filings indexed 564 across all filing types
Latest filing 2014-12-30 Regulatory Filings
Country US United States of America
Listing US RKDA

About Arcadia Biosciences, Inc.

https://arcadiabio.com/

Arcadia Biosciences, Inc. is a company focused on developing and marketing plant-based health and wellness products. With a foundation in agricultural innovation, the company cultivates next-generation ingredients and consumer goods. Its primary focus is a portfolio of specialty wheat ingredients designed to offer enhanced nutritional benefits, such as increased fiber, improved protein quality, reduced allergenic gluten, and higher amino acid content. Arcadia aims to transform wheat into a functional food ingredient, collaborating with food manufacturers to create healthier formulations of consumer products. In addition to its wheat ingredients, the company's brand portfolio includes Zola, a line of natural coconut water products.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2014
Regulatory Filings
2014-12-30 English
Regulatory Filings 2014
Regulatory Filings Classification · 95% confidence The document is a detailed letter from a law firm to the SEC regarding comments on a draft registration statement on Form S-1 for Arcadia Biosciences, Inc. It discusses amendments to the registration statement, responses to SEC comments, and detailed disclosures about the company's business, market, and regulatory environment. The presence of references to Form S-1, registration statement amendments, and SEC comment letters indicates this is part of a regulatory filing process related to a securities offering. The document is not an annual report, earnings release, or any other financial report but rather a regulatory filing related to a registration statement amendment. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length (15,000 characters) and content confirm it is not a brief announcement or certification but a substantive regulatory filing.
2014-12-22 English
Capital/Financing Update 2014
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed confidentially with the SEC under the Securities Act of 1933. It includes a preliminary prospectus for an initial public offering (IPO) of common stock by Arcadia Biosciences, Inc. The content includes detailed sections typical of an IPO prospectus such as risk factors, use of proceeds, capitalization, dilution, selected financial data, management discussion and analysis, business overview, management, executive compensation, principal stockholders, description of capital stock, underwriting, legal matters, and financial statements. This is a registration statement and prospectus related to capital raising and securities offering, not a financial report, earnings release, or management report. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is not merely an announcement or certification, so it is not RPA or RNS. Confidence is high due to clear identification of the document as a Form S-1 registration statement and IPO prospectus.
2014-12-22 English
Regulatory Filings 2014
Regulatory Filings
2014-12-08 English
Regulatory Filings 2014
Regulatory Filings Classification · 95% confidence The document is a letter from a law firm submitting a draft registration statement on Form S-1 confidentially to the SEC for review. It references the JOBS Act and discusses the timing and content of the registration statement, including financial statement requirements and anticipated updates. The document is not the registration statement itself but a submission letter related to the registration process. It is short (4243 characters) and serves as a communication about a regulatory filing rather than the filing itself. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory communications that do not fit other specific categories.
2014-11-12 English
Regulatory Filings 2014
Regulatory Filings Classification · 100% confidence The document is a Form S-1 Registration Statement filed confidentially with the SEC, as indicated by the header and references to the Securities Act of 1933. It includes a preliminary prospectus for an initial public offering (IPO) of common stock, with details about underwriting, risk factors, use of proceeds, capitalization, and other typical IPO disclosures. The document is not a financial report like an annual or quarterly report, nor is it an earnings release or management discussion. It is a regulatory filing related to securities registration and offering. Therefore, it fits best under the category of Regulatory Filings (RNS). The document length is substantial (15,000 characters), and it contains detailed registration and offering information, not just an announcement or certification.
2014-11-12 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.